NCT00102739 - SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG

SB497115

Trial Locations (30)

114

GSK Investigational Site, Taipei

1000

GSK Investigational Site, Ljubljana

1701

GSK Investigational Site, Auckland

2000

GSK Investigational Site, Maribor

10330

GSK Investigational Site, Bangkok

10676

GSK Investigational Site, Athens

40002

GSK Investigational Site, Khon Kaen

50000

GSK Investigational Site, Chiang Mai

54600

GSK Investigational Site, Lahore

57010

GSK Investigational Site, Thessaloniki

61231

GSK Investigational Site, Bad Nauheim

125167

GSK Investigational Site, Moscow

630087

GSK Investigational Site, Novosibirsk

Unknown

GSK Investigational Site, Athens

GSK Investigational Site, Pokfulam

GSK Investigational Site, Shatin

93-510

GSK Investigational Site, Lodz

022328

GSK Investigational Site, Bucharest

050098

GSK Investigational Site, Bucharest

105 229

GSK Investigational Site, Moscow

136-705

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

140-743

GSK Investigational Site, Seoul

RG1 7AN

GSK Investigational Site, Reading

TA1 5DA

GSK Investigational Site, Taunton

L7 8XP

GSK Investigational Site, Liverpool

E1 1BB

GSK Investigational Site, London

WC1E 6HX

GSK Investigational Site, London

M13 9WL

GSK Investigational Site, Manchester

SA6 6NL

GSK Investigational Site, Swansea